Skip to main content

Survival outcomes of patients (pts) who received filgrastim (fil) or pegfilgrastim (peg) in clinical trials.

Publication ,  Conference
Lyman, GH; Reiner, M; Morrow, PKH; Crawford, J
Published in: Journal of Clinical Oncology
May 20, 2014

Duke Scholars

Published In

Journal of Clinical Oncology

DOI

EISSN

1527-7755

ISSN

0732-183X

Publication Date

May 20, 2014

Volume

32

Issue

15_suppl

Start / End Page

e17612 / e17612

Publisher

American Society of Clinical Oncology (ASCO)

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Lyman, G. H., Reiner, M., Morrow, P. K. H., & Crawford, J. (2014). Survival outcomes of patients (pts) who received filgrastim (fil) or pegfilgrastim (peg) in clinical trials. In Journal of Clinical Oncology (Vol. 32, pp. e17612–e17612). American Society of Clinical Oncology (ASCO). https://doi.org/10.1200/jco.2014.32.15_suppl.e17612
Lyman, Gary H., Maureen Reiner, Phuong Khanh H. Morrow, and Jeffrey Crawford. “Survival outcomes of patients (pts) who received filgrastim (fil) or pegfilgrastim (peg) in clinical trials.” In Journal of Clinical Oncology, 32:e17612–e17612. American Society of Clinical Oncology (ASCO), 2014. https://doi.org/10.1200/jco.2014.32.15_suppl.e17612.
Lyman GH, Reiner M, Morrow PKH, Crawford J. Survival outcomes of patients (pts) who received filgrastim (fil) or pegfilgrastim (peg) in clinical trials. In: Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2014. p. e17612–e17612.
Lyman, Gary H., et al. “Survival outcomes of patients (pts) who received filgrastim (fil) or pegfilgrastim (peg) in clinical trials.Journal of Clinical Oncology, vol. 32, no. 15_suppl, American Society of Clinical Oncology (ASCO), 2014, pp. e17612–e17612. Crossref, doi:10.1200/jco.2014.32.15_suppl.e17612.
Lyman GH, Reiner M, Morrow PKH, Crawford J. Survival outcomes of patients (pts) who received filgrastim (fil) or pegfilgrastim (peg) in clinical trials. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2014. p. e17612–e17612.

Published In

Journal of Clinical Oncology

DOI

EISSN

1527-7755

ISSN

0732-183X

Publication Date

May 20, 2014

Volume

32

Issue

15_suppl

Start / End Page

e17612 / e17612

Publisher

American Society of Clinical Oncology (ASCO)

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences